- Home
- Automated
- List of product information
- EPHEDRINE AGUETTANT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 30 MG/ 10 ML [SIN16846P]
EPHEDRINE AGUETTANT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 30 MG/ 10 ML [SIN16846P]
Active ingredients: EPHEDRINE AGUETTANT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 30 MG/ 10 ML
Last updated 26 October 2025
Product Info
EPHEDRINE AGUETTANT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 30 MG/ 10 ML
[SIN16846P]
Product information
Active Ingredient and Strength | EPHEDRINE HYDROCHLORIDE - 30 MG/10 ML |
Dosage Form | INJECTION, SOLUTION |
Manufacturer and Country | LABORATOIRE AGUETTANT - FRANCE |
Registration Number | SIN16846P |
Licence Holder | INTEGA PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | C01CA26 |
4.1. Therapeutic indications
Reversal of anaesthesia induced hypotension during spinal and epidural anaesthesia
4.2. Dosage and method of administration
Adults and the elderly
Up to 30 mg in increments of 3 – 7.5 mg.
After the development of hypotension, by slow intravenous administration.
Paediatric Population
0.5 – 0.75 mg/kg body weight or 17 – 25 mg/m2 body surface.
After the development of hypotension, by slow intravenous administration.
Compatibilities
Ephedrine is reported to be compatible with 0.9% sodium chloride.
4.3. Contraindications
This medicinal product must never be used in the following cases:
hypersensitivity to the active substance or to any of the excipients listed in section 6.1 – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.
in combination with other indirect sympathomimetic agents such as pseudoephedrine, methylphenidate, bupropion, cafedrine, and theodrenaline.
in combination with alpha sympathomimetic agents.
in combination with irreversible monoamine oxidase inhibitors (MAOI).